AI-Mind: Artificial Intelligence for Dementia Prevention
2021-03-01 08:00 - 2026-02-28 17:00 (Europe/Oslo)
(PROJECT)

Accelopment Schweiz AG. “AI-Mind”. Accessed 13.08.2025. https://www.ai-mind.eu.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 964220. This website reflects only the author’s view and the Commission is not responsible for any use that may be made of the information it contains.

What is the challenge?

There are over 50 million people worldwide living with dementia and by 2030 this number is expected to reach 82 million.

The ageing brain becomes vulnerable to decline and keeping independency in daily life can become a challenge for the elderly. People with Mild Cognitive Impairment (MCI), an intermediate condition between normal brain ageing and dementia, may develop dementia in the future.

There is an urgent need for early risk assessment and intervention. Current practices with time-consuming patient investigations focus on late symptoms management due to a lack of diagnostic tools. This causes numerous implications in terms of familial, medical and care costs.

With AI-Mind we aim to reduce the disease’s burden by developing novel, AI-based tools to support healthcare professionals in their diagnosis and offering timely interventions to patients.

At the heart of AI-Mind is our research study, that

Takes place in Norway, Finland, Italy and Spain and will involve 1,000 participants.

Helps to develop and validate artificial intelligence (AI) based tools to predict who is likely to develop dementia.

The AI-Mind project aims to ease the burden of dementia by creating innovative, AI-driven tools that assist healthcare professionals in predicting dementia risks in patients affected by mild cognitive impairment (MCI). Most dementia treatments focus on managing symptoms once they appear, leaving little room for early prevention. AI-Mind seeks to transform this process by replacing complex and inefficient screening methods with advanced, automated tools powered by AI. These tools will address the critical need for early and precise diagnosis, allowing doctors to identify patients at high risk of developing dementia with greater confidence.
